schizoaffective depressive type
Selected indexed studies
- Risk Factors, Clinical Features, and Polygenic Risk Scores in Schizophrenia and Schizoaffective Disorder Depressive-Type. (Schizophr Bull, 2021) [PMID:33837784]
- Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. (Lancet, 2018) [PMID:30177236]
- Cariprazine-induced mania: A case series report. (Bipolar Disord, 2022) [PMID:34797609]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. (2018) pubmed
- Cariprazine-induced mania: A case series report. (2022) pubmed
- Risk Factors, Clinical Features, and Polygenic Risk Scores in Schizophrenia and Schizoaffective Disorder Depressive-Type. (2021) pubmed
- Absolute and relative risks of mental disorders in families: a Danish register-based study. (2025) pubmed
- A family study of DSM-III-R schizoaffective disorder, depressive type, compared with schizophrenia and psychotic and nonpsychotic major depression. (1991) pubmed
- Examining cognition across the bipolar/schizophrenia diagnostic spectrum. (2018) pubmed
- Oedipism and Self-Amputation in a Schizoaffective, Depressed Type Patient: To Heal or Feel Pain? (2021) pubmed
- Long-Acting Injectable Antipsychotics in Adolescents with Bipolar Disorder. (2025) pubmed
- Pharmacologic treatment of schizoaffective disorder. (1994) pubmed
- Asenapine versus placebo for schizophrenia. (2015) pubmed